
|Slideshows|May 22, 2019
4 FDA-Approved Continuous Glucose Monitoring Systems: An Update
Author(s)Veronica Hackethal, MD
Refresh your memory of 4 CGM systems that received FDA-approval in 2018. Each one offers innovative features to help enhance diabetes care.
Advertisement
In 2018, the FDA issued approvals for several continuous glucose monitors (CGMs), and an expanded indication for a closed-loop artificial pancreas system. Since then, these systems have been rolled out and are currently being marketed in the US. This short slideshow offers compact summaries on 4 of these products which all offer innovative features like extended sensor wear-time, elimination of daily finger stick calibration, and integration with Siri and Google Fit apps.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Patient Care Online
1
FDA Approves Pfizer-BioNTech XFG-Adapted COVID-19 Vaccine for 2026-27 Season
2
Intensive Blood Pressure Control in Primary Care May Lower Dementia Risk
3
Independent Review Supports Respiratory Virus Immunizations for 2026-27 Season
4
Diagnosing PMOS in Adolescents: Criteria, Ultrasound Limits, and Red Flags
5


























































































































